earnings

SINGAPORE (Feb 28): Straits Trading Company saw its 4Q18 earnings nearly treble to $14.1 million from $5.2 million a year ago, mainly due to higher other items of income as well as reduced other items of expense.

SINGAPORE (Feb 28): CITIC Envirotech Limited (CEL) has concluded FY18 with earnings of $113.2 million, rising 41.6% from its FY17 earnings of $79.9 million on higher revenue.

SINGAPORE (Feb 28): Indofood Agri Resources (IndoAgri) has sunk into a loss of Rp 211.7 billion ($20 million) for 4Q18 compared to Rp 76.9 billion in profit a year ago, due to significantly lower profit in the Plantation Division arising from weak commodi

SINGAPORE (Feb 27): Yeo Hiap Seng has announced earnings of $1.8 million for the 4Q ended Dec 2018, up 20% from 4Q17 earnings of $1.5 million due to better margins as well as lower fair value losses on equity investments.

SINGAPORE (Feb 27): Nam Cheong announced earnings of RM9.7 million for the 4Q ended Dec 2018, reversing from its loss of RM987.5 million in 4Q17 mainly a result of a waiver of debts.

SINGAPORE (Feb 25): Raffles Medical Group (RMG) announced $71.1 million in earnings for FY18, rising a marginal 0.4% from $70.8 million in FY17 as higher tax expenses and additional depreciation from the recently-completed Raffles Specialist Centre contin

SINGAPORE (Feb 22): Maybank Kim Eng, OCBC Investment Research, RHB Research and CGS-CIMB Research are maintaining their “buy” calls on Genting Singapore (GENS) with the respective target prices of $1.26, $1.31, $1.22 and $1.28.  

SINGAPORE (Feb 21): Sembcorp Industries reported earnings of $106 million for the 4Q ended Dec 2018, representing a 10% decline from restated 4Q17 earnings of $118 million as the Marine segment continued to impact the absorption of overhead costs.

SINGAPORE (Feb 21): Genting Singapore (GENS) announced earnings of $150.2 million for the 4Q ended Dec 2018, rising 12% y-o-y from its earnings of $134 million in 4Q17 due to higher revenue.

SINGAPORE (Feb 21): CGS-CIMB Research, DBS Vickers Securities and OCBC Investment Research are maintaining “buy” on CapitaLand with the respective price targets of $3.56, $3.62 and $3.98, after the group posted 71.2% higher earnings of $476 million fo